Tempus AI Inc. TEM investors have a decision to make. Shares of the precision medicine company fell nearly 6% Monday, taking ...
Eric Lefkofsky's Tempus AI drew overflowing investor demand before pricing its Nasdaq IPO on Thursday at the top of the range for proceeds of US$410.7m and staging a solid debut on Friday. The ...